JNJ-80202135, JNJ-80202135, Saline, 0.9% Sodium Chloride Solution for Injection
80202135IIM2001
Phase 2 small_molecule active
Quick answer
JNJ-80202135, JNJ-80202135, Saline, 0.9% Sodium Chloride Solution for Injection for Active Idiopathic Inflammatory Myopathies (IIM) is a Phase 2 program (small_molecule) at Janssen-Cilag International N.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Janssen-Cilag International N.V.
- Indication
- Active Idiopathic Inflammatory Myopathies (IIM)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active